Boston Scientific Other countries — Long-Lived Assets increased by 6.9% to $730.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 8.6%, from $672.00M to $730.00M.
An increase suggests expanding infrastructure or capital investment in these regions, while a decrease may indicate asset divestiture, impairment, or a shift in manufacturing strategy.
This metric represents the total book value of non-current, physical, and intangible assets held by the company in geogr...
Peers in the medical device industry typically report similar geographic breakdowns of property, plant, and equipment to demonstrate their global supply chain and manufacturing distribution.
bsx_segment_other_countries_long_lived_assets| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|
| Value | $625.00M | $481.00M | $587.00M | $672.00M | $654.00M | $656.00M | $683.00M | $730.00M |
| QoQ Change | — | -23.0% | +22.0% | +14.5% | -2.7% | +0.3% | +4.1% | +6.9% |
| YoY Change | — | -23.0% | +22.0% | +14.5% | — | — | — | +8.6% |